Accumed Biotech Technologies LLC., AdvaCare International and Church and Dwight Co. Inc. will emerge as major participants in the ovulation test market during the forecast period
NEW YORK, 3 December 2021 / PRNewswire / – The ovulation test market is fragmented, and sellers use various organic and inorganic growth strategies to compete in the market. The ovulation test market is expected to USD 178.68 million from 2021 to 2026, according to Technavio.
Download preview now to explore growth opportunities in the ovulation test market
Analysis of key market participants
-
Accumed Biotech Technologies LLC. – The company offers AccuMed One Step LH Ovulation Test Strips.
-
AdvaCare International – The company offers AccuQuik test kits.
-
Church and Dwight Co. Inc. – The company offers ovulation tests under its brand First Response with the product Ovulation Plus Pregnancy Test.
Subscribe to Technavios “Lite Plan” which is invoiced annually at USD 3000. View 3 reports monthly and download 3 reports annually!
Ovulation Test Market 2022-2026: Segmentation
Based on segmentation by type, the market growth share of the color ovulation test segment is expected to be significant during the forecast period. These kits are economical and consumer friendly as compared to digital ovulation test kits. The increasing number of couples trying to conceive is the main driver for the growth of the color ovulation set market.
Based on segmentation by geography, 35% of market growth is excluded, coming from Asia during the forecast period. China is the key country for the market for ovulation tests Asia. Market growth in this region will be faster than the growth of the market in regions. The rising age of pregnancy among women will drive the growth of the ovulation test market Asia during the forecast period.
Managers and challenges
Ovulation tests are used to monitor the menstrual cycle of women to find the best days to get pregnant. Monitoring ovulation increases the chance of pregnancy among women over the age of 30. The ovulation test market is driven by the rising age of pregnancy among women, increasing demand for home test devices and easy availability of ovulation devices.
Factors such as highly expensive ovulation test kits can hinder market growth. In developing countries, the high price of ovulation test kits discourages people from buying it.
View a report example to learn more about the drivers, challenges and trends affecting market growth
Reports that may interest you:
-
Artificial insemination market: The market for artificial insemination is segmented by end users (commercial users and individual users) and geography (North America, Europe, Asiaand RY). Download sample report now
-
In-vitro diagnostic market: The in vitro diagnostics market is segmented by technology (immunochemistry, molecular diagnostics, tissue diagnostics, hematology, and others) and geography (North America, Europe, Asiaand RY). Download sample report
|
Ovulation Test Market Scope |
|
|
Report coverage |
Details |
|
Page number |
120 |
|
Base year |
2021 |
|
Forecast period |
2022-2026 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 3.99% |
|
Market growth 2022-2026 |
USD 178.68 million |
|
Market structure |
Fragmented |
|
Yes-year growth (%) |
3.54 |
|
Regional analysis |
North America, Europe, Asia and ROW |
|
Execution of market contribution |
Asia at 35% |
|
Key Consumer Countries |
USA, Germany, UK, Canada and China |
|
Competitive landscape |
Leading companies, competitive strategies, scope of consumer engagement |
|
Companies profiled |
Accumed Biotech Technologies LLC. , AdvaCare International, Church and Dwight Co. Inc., Fairhaven Health LLC, Fertility Focus Ltd., Geratherm Medical AG, Nectar Lifesciences Ltd., Philippine Blue Cross Biotech Corp., Swiss Precision Diagnostics GmbH, and UEBE Medical GmbH |
|
Market dynamics |
Parent Market Analysis, Market Growth Inducers and Obstacles, Fast Growing and Slow Growing Segment Analysis, COVID-19 Impact and Future Consumer Dynamics, Market Condition Analysis for Forecast Period |
|
Adjustment scope |
If our report did not include the data you are looking for, you can reach out to our analysts and customize segments. |
About us
Technavio is a leading global technology research and consulting company. Their research and analysis focuses on emerging market trends and provides feasible insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With more than 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counts, covering 800 technologies, spanning 50 countries. Their customer base consists of businesses of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, extensive research and feasible market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Tegnavio Research
Jesse Maida
Media & Marketing Manager
USA: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download multimedia: https://www.prnewswire.com/news-releases/ovulation-test-market-size-to-increase-by-usd-178-68-million–technavio-301436413. html
SOURCE Technavio
English
French
Spanish